April 2, 2020
Tag: Bladder Cancer Clinical Program
March 17, 2020
Studying wearable devices to connect patients and doctors after surgery
Research led by Lixin Song, PhD, RN, FAAN, uses wearable technology to monitor colon and bladder cancer patients for complications when they’re home after surgery.
February 17, 2020
UroToday: Risk Stratification and Management of High-Risk Muscle-Invasive Urothelial Carcinoma: Subtyping of High-risk Muscle Invasive Urothelial Carcinoma
June 19, 2019
Doctor sets sights on bladder cancer breakthroughs
For Matthew Milowsky, MD, the George Gabriel and Frances Gable Villere Distinguished Professor of Bladder and Genitourinary Cancer Research, the why of genitourinary cancers is just as important to him as the how and what. As a former philosophy major, it’s natural that the questions behind these cancers are what drive the clinician and researcher to explore new methods to treat and care for patients.
April 30, 2019
Smith named director of urologic oncology, co-director of the Multidisciplinary Genitourinary Oncology Service
UNC Lineberger’s Angela B. Smith, MD, MS, FACS, has been named director of Urologic Oncology in the UNC Department of Urology and co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital, UNC Lineberger’s clinical home.
May 21, 2018
Bladder cancer model could pave the way for better drug efficacy studies
In the journal Cancer Research, UNC Lineberger’s William Y. Kim, MD, Benjamin G. Vincent, MD, and colleagues reported they have developed a mouse model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer. The researchers said this model may help them to determine which patients may respond to immunotherapy treatments called checkpoint inhibitors.
April 23, 2015
Roger Johnson
Siler City native Roger Johnson knows the value of personalized medicine. After being diagnosed with bladder cancer in 2013, physicians at UNC sequenced his tumor to better understand the genetics driving his cancer.
February 10, 2015
Smith awarded funding to identify research topics that matter most to patients
UNC Lineberger's Smith was awarded a contract by the Patient-Centered Outcomes Research Institute to find the research questions that matter most to bladder cancer patients.
July 8, 2014
Kim receives 2014 Bladder Cancer Research Innovation Award
The Bladder Cancer Advocacy Network (BCAN) has awarded William Kim, MD, associate professor of medicine, urology, and genetics, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center, with the 2014 Bladder Cancer Research Innovation Award to support his project “Immune Characterization of High-Grade Bladder Cancer.”
June 20, 2014
WRAL story highlights bladder cancer vaccine study at UNC
A story that ran on Raleigh-based CBS affiliate WRAL focuses on a new bladder cancer vaccine being studied at UNC, called Impact Therapy. The vaccine works to target cancer cells with minimal side effects.